SUBSCribe
logo
twitterlinkedininstagramUser Profile
search
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • Spotlight Initiatives
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
        • The Outperformers (51-60)

          These companies have been ranked based on their stock's excess return over the Sensex for a five-year period

          September 03, 2019
        • The Keymakers

          With a powerful client base and an all-in-one package, the contract R&D firm Syngene is galloping ahead and now even into manufacturing 

          Shruti Venkatesh - May 17, 2019
        • Injecting Growth

          By focusing on its strength in manufacturing lyophilized injectables, Gufic Biosciences has made a strong comeback and wants to aggressively push into the EU market next

          Jash Kriplani - April 16, 2018
        • Is the worst over for pharma stocks?

          The pharma index has hugely underperformed the Sensex in CY17 owing to regulatory overhang and FDA issues 

          July 17, 2017
        • Under The Weather- Part 1

          The domestic pharma industry, which is already battling the US FDA, has now to contend with regulatory challenges at home

          Krishna Gopalan - May 20, 2017
        • Under The Weather - Part 2

          Even as it battles the US FDA, the industry has been caught off-guard by policy changes back home

          Krishna Gopalan - June 05, 2017
        • One giant leap for Mankind

          Mankind Pharma made it big in small towns, but can its magic help it conquer the bigger markets?

          Himanshu Kakkar - January 21, 2016
        • Will Sun rise again?

          Can Sun Pharma’s Dilip Shanghvi work his merger magic on Ranbaxy?

          Kripa Mahalingam - June 15, 2015
        • Hot wheels

          Nephroplus’ Vikram Vuppala’s eight-wheelers can outrun any fancy car

          Aditi Saxena - June 17, 2015
        • "If you believe in something, have the courage to take it to completion"

          The Piramal group head on how his values have helped him make bold business decisions

          N Mahalakshmi - December 21, 2015